Hematology

BioIT Alliance begins the Biomarker Project and recruits Agilent.

Microbial resistance to antibiotics is a growing problem, but rather than develop more powerful drugs

Developer of antibody fragment therapeutics recently announced the spin-out of its small-molecule inhibitor programs.

Applied Biosystems and GeneGo collaborate to integrate ABI\'s Tissue Gene Expression Database into the MetaCore data mining platform.

A pilot service agreement between Iconix and Merck is drawing on Iconix’s toxicogenomics technology to perform in vitro studies of Merck compounds.

Both parties obtain “substantial freedom” to conduct research under certain of each other’s IP and develop therapeutic, prophylactic and diagnostic products.

Agreement to be acquired by Switch Pharma Ltd. expected to close on Sept. 30, subject to requisite approvals.

Advances in genomics, proteomics, and metabolomics over the last decade have provided an unprecedented, exquisitely detailed view into the molecular nature of disease and treatment. Biomarkers are among the most practical tools arising from the “omics” revolution.

DiscoveRx Corp., which thus far has been known primarily for being the provider of the off-the-shelf HitHunter assays, has made things personal—or at least personalized—by launching custom labeling and profiling services.

PerkinElmer has expanded and deepened its screening and diagnostics offerings with the acquisition of Spectral Genomics’ assets for molecular karyotyping technology used to evaluate chromosomal abnormalities.